DEVELOPMENT OF MUTANT HUMAN IMMUNOREACTIVE TRYPSINOGEN (IRT) FOR USE IN IMMUNOASSAYS
In this thesis, it is aimed to develop recombinant IRT proteins that do not have a proteolytic activity to be used as a standard in Immunoreactive Trypsinogen (IRT) ELISA kits. IRT is a protein used as a marker for the diagnosis of cystic fibrosis (CF) in newborns. In addition to CF; diabetes, pancreatitis, and pancreatic cancer are possible fields for
M Divyapicigil +4 more
openaire +3 more sources
Modifying an enzyme immunoassay of immunoreactive trypsinogen to use time-resolved fluorescence
Abstract A coated microtiter-well, enzyme-linked immunometric assay for quantifying immunoreactive trypsinogen in dried blood spots was modified to use time-resolved fluorescence of europium in place of end-point enzymatic color development as the quantification step.
R G, Ryall +3 more
openaire +2 more sources
Cystic fibrosis: current concepts
Cystic fibrosis is an autosomal recessive genetic disease, mainly in Caucasian children and young adults. It is caused by pathogenic variants in the CFTR (cystic fibrosis transmembrane conductance regulator) gene, which results in increased viscosity and
Jaime A. López-Valdez +6 more
doaj +1 more source
Residual DBS specimens from newborns diagnosed with Phenylketonuria, Congenital Hypothyroidism, Cystic Fibrosis, Congenital Adrenal Hyperplasia and Galactosemia collected within 1995-2018, stored in cardboard boxes at ambient temperature in uncontrolled ...
Gustavo J.C. Borrajo, Vanina V. Doña
doaj +1 more source
Determination of human pancreatic cationic trypsinogen in serum by radioimmunoassay. [PDF]
A specific radioimmunoassay has been developed for human pancreatic cationic trypsin. The assay has been employed for the determination of immunoreactive forms of pancreatic cationic trypsin in blood.
J W Brodrick +3 more
core +1 more source
Immunoreactive Trypsinogen Levels in Infants Born to Women with Cystic Fibrosis Taking Elexacaftor-Tezacaftor-Ivacaftor [PDF]
Background/Objective:Cystic Fibrosis (CF) is a lethal autosomal recessive disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene affecting people of every race and ethnicity in the US.
Sanders, Don B. +6 more
core +4 more sources
Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis [PDF]
To assess the effectiveness of a two tier neonatal screening strategy for cystic fibrosis, which combines estimation of immunoreactive trypsinogen followed by direct gene analysis in dried blood spot samples collected at age 5 days.Prospective study of two tier screening strategy.
E, Ranieri +6 more
openaire +2 more sources
The first five-year evaluation of cystic fibrosis neonatal screening program in São Paulo State, Brazil [PDF]
The Hospital of the Ribeirão Preto Medical School, University of São Paulo is one of the three screening centers in São Paulo State, Brazil, and has included a test for cystic fibrosis (CF) since February 6, 2010, by a court order. We evaluated the first
Léa Maria Zanini Maciel +8 more
doaj +1 more source
Molecular forms of immunoreactive pancreatic cationic trypsin in pancreatitis patient sera. [PDF]
The molecular forms of immunoreactive pancreatic cationic trypsin in sera of patients with acute pancreatic inflammation have been characterized using a radioimmunoassay technique that is capable of detecting trypsinogen as well as trypsin bound to alpha
J W Brodrick +4 more
core +1 more source
Background. Cystic fibrosis (CF) is a multisystemic, autosomal recessive disease, which is caused by a mutation in the transmembrane conduction regulator protein (CFTR) gene.
Aslı İmran Yılmaz +4 more
doaj +1 more source

